The last decade has seen a swell of biotech startups using AI to design proteins. These are seven companies to watch.
David H. Holman, Lestin L. Kenton Jr. and Kristina Caggiano Kelly of Sterne, Kessler, Goldstein & Fox PLLC discuss ...
On the heels of its most advanced medicine flunking a key study, the drugmaker is looking at the different paths it could ...
Crescent Biopharma is advancing a drug its CEO claims is “purpose-built” to be a perfected version of Summit Therapeutics’ ...
Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...
Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise. Bright Minds shares DRUG ...
Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...
Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...
Paramesu Biotech, a leading maize-based products manufacturer, files IPO papers with Sebi to raise Rs 600 crore. The IPO ...
Q3 2024 Earnings Call Transcript October 29, 2024 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $ ...
A new class of nanostructures is capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both ...